EN
HI
Summary
As of 19 Oct, 2026, Thyrocare Technologies stock price is ₹471. During the trading session, the stock has moved between an intraday low of ₹466.50 and an intraday high of ₹488.55. Over the last 52 weeks, Thyrocare Technologies has traded between ₹342.55 and ₹1610.00.
The stock has recorded a trading volume of 1,86,829 shares,. Its Average Traded Price (ATP) is ₹475.65, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 3 @ ₹471.00.
Thyrocare Technologies has an upper circuit limit of ₹582.30 and a lower circuit limit of ₹388.20. The total value traded stands at ₹8.89 CR, and the delivery percentage for the day is 59.29%.
The stock is currently traded with a market lot size of 1. Thyrocare Technologies also offers a dividend yield of 2.88%.
Thyrocare Technologies Share Price Chart
Thyrocare Technologies Share Key Metrics
Volume
1.87 L
Market Cap
7496.69 CR
LTQ@LTP
3@471.00
ATP
475.65
Var Margin
19.44 %
Circuit Range
388.2-582.3
Delivery %
59.29 %
Value
8.89 CR
ASM/GSM
No
Market Lot
1
Thyrocare Technologies Fundamentals
P/E Ratio
43.89
P/B Ratio
12.29
Div. Yield
2.88
Sector P/E
52.97
Sector P/B
-13.88
Sec. Div. Yield
0.19
Thyrocare Technologies Resistance and Support
Pivot 485.28
Resistance
First Resistance
489.86
Second Resistance
494.48
Third Resistance
499.06
Support
First Support
480.66
Second Support
476.08
Third Support
471.46
Thyrocare Technologies Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Mon Oct 19 2026 | 488.55 | 471 | -2.94% | 488.55 | 466.5 |
| Fri Oct 16 2026 | 489.89 | 485.25 | -0.47% | 489.89 | 480.7 |
| Thu Oct 15 2026 | 492 | 487.54 | -1.27% | 495.75 | 484.35 |
Thyrocare Technologies Corporate Actions
| Date | Agenda |
|---|---|
| 2026-07-23 | Quarterly Results |
| 2026-05-07 | Audited Results & Final Dividend |
| 2026-01-28 | Quarterly Results |
| 2025-10-14 | Qtr Results |
| 2025-07-23 | Quarterly Results |
| 2025-04-23 | Audited Results & Final Dividend |
| 2025-01-23 | Quarterly Results |
| 2024-10-23 | Quarterly Results |
Thyrocare Technologies News
Thyrocare Technologies Ltd - 539871 - Sale Of The Entire Shareholding Held By The Company In Nueclear Healthcare Limited (A Material Wholly Owned Subsidiary), Subject To The Approval Of The Shareholders Of The Company
Thyrocare Technologies' board approved the divestment of its wholly-owned subsidiary, Nueclear Healthcare Limited (NHL), for Rs. 141.40 crore. The move allows the company to exit the radiology business and focus on its core pathology operations.
Sep 21 2026 15:06:23
Thyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Acquisition
Thyrocare Technologies' Board approved acquiring 42,500 Compulsorily Convertible Preference Shares (CCPS) of Trovera Healthcare Private Limited for Rs. 59.5 crore. This acquisition is part of the consideration for divesting its entire 100% shareholding in Nueclear Healthcare Limited, its radiology business.
Sep 21 2026 15:02:22
Read More
Thyrocare Technologies Management
| Name | Position |
|---|---|
| Brijesh Kumar | Company Secretary & Compliance Officer |
| Rahul Guha | Chairman, Managing Director & Chief Executive Officer |
Thyrocare Technologies Similar Stocks
Procter & Gamble Health Ltd.
5135.50
-64.50 (1.24%)
Suven Life Sciences Ltd.
290.05
-13.50 (4.45%)
Symbiotec Pharmalab Ltd.
1238.60
-40.90 (3.20%)
Jupiter Life Line Hospitals Ltd.
243.90
-3.15 (1.28%)
Aarti Pharmalabs Ltd.
832.35
-41.30 (4.73%)
Bliss GVS Pharma Ltd.
627.05
-24.95 (3.83%)
Morepen Laboratories Ltd.
121.49
-2.38 (1.92%)
Sanofi India Ltd.
2880.30
-61.80 (2.10%)
Kovai Medical Center & Hospital Ltd.
5875.00
-98.00 (1.64%)
Nephrocare Health Services Ltd.
611.55
-2.80 (0.46%)
Thyrocare Technologies FAQs
The Buying Price of Thyrocare Technologies share is 471 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Thyrocare Technologies stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Thyrocare Technologies, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Thyrocare Technologies shares is 43.89. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Thyrocare Technologies shares is 12.29. Useful to assess the stock's value relative to its book value.
To assess Thyrocare Technologies’s valuation compare Sector P/E, P/B which are 52.97 & -13.88 with sector averages, along with growth rates and financial metrics.
The Market Cap of Thyrocare Technologies is 7496.69 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Thyrocare Technologies share price is 1610.00 & 342.55. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Thyrocare Technologies belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in THYROCARE
